busPIRone Hydrochloride Tablets
Subpotent drug
Yes — there is an active recall. 2 ongoing FDA recalls mention Buspirone (10 total). Check the affected lots below.
Most common reason: cGMP deviation (6 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Buspirone. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Subpotent drug
Presence of Foreign Tablets: Potential of stray tablet(s) of Amlodipine Besylate 10 mg Tablet within the recalled lots
CGMP Deviations
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
CGMP Deviations: recalling drug products following an FDA inspection.
Presence of Foreign Tablets/Capsules
Failed Impurity /Degradation Specifications
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.